The prion hypothesis of Parkinson's disease
Y Chu, JH Kordower - Current neurology and neuroscience reports, 2015 - Springer
The discovery of alpha-synuclein's prion-like behaviors in mammals, as well as a non-
Mendelian type of inheritance, has led to a new concept in biology, the “prion hypothesis” of …
Mendelian type of inheritance, has led to a new concept in biology, the “prion hypothesis” of …
Prion-like mechanisms in Parkinson's disease
J Ma, J Gao, J Wang, A Xie - Frontiers in neuroscience, 2019 - frontiersin.org
Formation and aggregation of misfolded proteins in the central nervous system (CNS) is a
key hallmark of several age-related neurodegenerative diseases, including Parkinson's …
key hallmark of several age-related neurodegenerative diseases, including Parkinson's …
Carboxy-terminal truncation and phosphorylation of α-synuclein elongates survival in a prion-like seeding mouse model of synucleinopathy
ZA Sorrentino, E Hass, N Vijayaraghavan, KM Gorion… - Neuroscience …, 2020 - Elsevier
Pathologic intracellular inclusions formed from polymers of misfolded α-synuclein (αsyn)
protein define a group of neurodegenerative diseases termed synucleinopathies which …
protein define a group of neurodegenerative diseases termed synucleinopathies which …
Parkinson's disease: A prionopathy?
S Vascellari, A Manzin - International journal of molecular sciences, 2021 - mdpi.com
The principal pathogenic event in Parkinson's disease is characterized by the
conformational change of α-synuclein, which form pathological aggregates of misfolded …
conformational change of α-synuclein, which form pathological aggregates of misfolded …
Parkinson's disease as a member of Prion-like disorders
ME Herva, MG Spillantini - Virus research, 2015 - Elsevier
Parkinson's disease is one of several neurodegenerative diseases associated with a
misfolded, aggregated and pathological protein. In Parkinson's disease this protein is alpha …
misfolded, aggregated and pathological protein. In Parkinson's disease this protein is alpha …
Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics
Parkinson's disease (PD) and multiple system atrophy (MSA) are distinct clinical syndromes
characterized by the pathological accumulation of α-synuclein (α-syn) protein fibrils in …
characterized by the pathological accumulation of α-synuclein (α-syn) protein fibrils in …
[HTML][HTML] The function of α-synuclein
JT Bendor, TP Logan, RH Edwards - Neuron, 2013 - cell.com
Human genetics has indicated a causal role for the protein α-synuclein in the pathogenesis
of familial Parkinson's disease (PD), and the aggregation of synuclein in essentially all …
of familial Parkinson's disease (PD), and the aggregation of synuclein in essentially all …
[HTML][HTML] α-Synuclein misfolding and Parkinson's disease
Substantial evidence links α-synuclein, a small highly conserved presynaptic protein with
unknown function, to both familial and sporadic Parkinson's disease (PD). α-Synuclein has …
unknown function, to both familial and sporadic Parkinson's disease (PD). α-Synuclein has …
A critical review of the prion hypothesis of human synucleinopathies
G Tamgüney, AD Korczyn - Cell and tissue research, 2018 - Springer
Abstract Parkinson's disease (PD), dementia with Lewy bodies (DLB), and multiple system
atrophy (MSA) are neurodegenerative disorders which have been pathologically classified …
atrophy (MSA) are neurodegenerative disorders which have been pathologically classified …
Calling α-synuclein a prion is scientifically justifiable
JC Watts - Acta Neuropathologica, 2019 - Springer
For more than a decade, the “prion-like” hypothesis for Parkinson's disease (PD) has
remained one of the most controversial topics in neurodegenerative disease research [21 …
remained one of the most controversial topics in neurodegenerative disease research [21 …